These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 30517930)
1. Dialysate Calcium Levels: Do They Matter? van der Sande FM; Ter Meulen KJA; Kotanko P; Kooman JP Blood Purif; 2019; 47(1-3):230-235. PubMed ID: 30517930 [TBL] [Abstract][Full Text] [Related]
2. Calcium kinetics and the long-term effects of lowering dialysate calcium concentration. Argilés A; Kerr PG; Canaud B; Flavier JL; Mion C Kidney Int; 1993 Mar; 43(3):630-40. PubMed ID: 8455362 [TBL] [Abstract][Full Text] [Related]
3. Biological impact of targeted dialysate calcium changes in haemodialysis patients: the key role of parathyroid hormone. Jean G; Mayor B; Hurot JM; Deleaval P; Lorriaux C; Zaoui E; Chazot C Nephrol Dial Transplant; 2013 Jan; 28(1):176-82. PubMed ID: 22764192 [TBL] [Abstract][Full Text] [Related]
4. Effects of Lowering Dialysate Calcium Concentration on Mineral and Bone Disorders in Chronic Hemodialysis Patients: Conversion from 3.0 mEq/L to 2.75 mEq/L. Yamada S; Ueki K; Tokumoto M; Suehiro T; Kimura H; Taniguchi M; Fujimi S; Kitazono T; Tsuruya K Ther Apher Dial; 2016 Feb; 20(1):31-9. PubMed ID: 26482334 [TBL] [Abstract][Full Text] [Related]
5. Paricalcitol treatment of secondary hyperparathyroidism in hemodialysis patients on sevelamer hydrochloride: which dialysate calcium concentration to use? Sonikian M; Metaxaki P; Karatzas I; Vlassopoulos D Blood Purif; 2009; 27(2):182-6. PubMed ID: 19141997 [TBL] [Abstract][Full Text] [Related]
6. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis. Brandi L Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159 [TBL] [Abstract][Full Text] [Related]
7. High-normal calcium (1.35 mmol/l) dialysate in patients on CAPD: efficient and safe long-term control of plasma calcium, phosphate, and parathyroid hormone. Bro S; Brandi L; Olgaard K Nephrol Dial Transplant; 1996 Aug; 11(8):1586-91. PubMed ID: 8856216 [TBL] [Abstract][Full Text] [Related]
8. Calcium balance in dialysis is best managed by adjusting dialysate calcium guided by kinetic modeling of the interrelationship between calcium intake, dose of vitamin D analogues and the dialysate calcium concentration. Gotch F; Levin NW; Kotanko P Blood Purif; 2010; 29(2):163-76. PubMed ID: 20093823 [TBL] [Abstract][Full Text] [Related]
9. [Hemodialysis with 2.5 mEq/L of calcium in relative hypoparathyroidism: long-term effects on bone mass]. Sánchez Perales MC; García Cortés MJ; Borrego FJ; Fernández Martínez S; Borrego J; Pérez del Barrio P; Liébana A; Pérez Bañasco V Nefrologia; 2000; 20(3):254-61. PubMed ID: 10917002 [TBL] [Abstract][Full Text] [Related]
10. Dialysate calcium individualisation: a pending issue. Maduell F; Rodríguez N; Arias-Guillén M; Jiménez S; Alemany B; Durán C; Fontseré N; Vera M; Carrera M; Arcal C; Pérez N; Cases A; Campistol JM Nefrologia; 2012; 32(5):579-86. PubMed ID: 23013943 [TBL] [Abstract][Full Text] [Related]
11. QTc dispersion increases during hemodialysis with low-calcium dialysate. Näppi SE; Virtanen VK; Saha HH; Mustonen JT; Pasternack AI Kidney Int; 2000 May; 57(5):2117-22. PubMed ID: 10792632 [TBL] [Abstract][Full Text] [Related]
12. Effect of dialysate calcium concentrations on parathyroid hormone and calcium balance during a single dialysis session using bicarbonate hemodialysis: a crossover clinical trial. Basile C; Libutti P; Di Turo AL; Vernaglione L; Casucci F; Losurdo N; Teutonico A; Lomonte C Am J Kidney Dis; 2012 Jan; 59(1):92-101. PubMed ID: 22000728 [TBL] [Abstract][Full Text] [Related]
13. Clinical benefit of the change of dialysate calcium concentration from 3.0 to 2.75 mEq/L. Sakai Y; Otsuka T; Ohno D; Murasawa T; Sakai S; Tsuruoka S Ther Apher Dial; 2014 Apr; 18(2):181-4. PubMed ID: 24720409 [TBL] [Abstract][Full Text] [Related]